Premium
Beam Therapeutics Inc (BEAM)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Mr. John M. EvansCEO & Director | -30,08k | 739,32k | Automatic Disposition | 24,58 | 949,27k | -3,07% |
| 2026-04-01 | Dr. Amy SimonChief Medical Officer | -6,70k | 164,69k | Automatic Disposition | 24,58 | 17,86k | -27,28% |
| 2026-04-01 | Dr. Christine P. BellonChief Legal Officer & Corporate Secretary | -5,96k | 146,40k | Automatic Disposition | 24,58 | 109,71k | -5,15% |
| 2026-04-01 | Ms. Bethany J. CavanaghSenior VP of Finance, Treasurer & Principal Accounting Officer | -3,24k | 79,69k | Automatic Disposition | 24,58 | 13,42k | -19,46% |
| 2026-04-01 | Dr. Giuseppe CiaramellaPresident | -11,81k | 290,29k | Automatic Disposition | 24,58 | 218,41k | -5,13% |
| 2026-03-30 | Mr. John M. EvansCEO & Director | -50,00k | 1,09M | Derivative Exercise and Sale | 0,67 - 22,76 | 978,73k | - |
| 2026-02-24 | Dr. Giuseppe CiaramellaPresident | -35,00k | 525,04k | Derivative Exercise and Sale | 17,00 - 32,00 | 115,22k | - |
| 2026-01-29 | Mr. John M. EvansCEO & Director | -50,00k | 1,41M | Derivative Exercise and Sale | 0,67 - 29,74 | 911,86k | - |
| 2026-01-22 | Dr. Christine P. BellonChief Legal Officer & Corporate Secretary | -1,37k | 46,61k | Automatic Disposition | 34,00 | 42,54k | -3,12% |
| 2026-01-22 | Ms. Bethany J. CavanaghSenior VP of Finance, Treasurer & Principal Accounting Officer | -6,20k | 216,93k | Automatic Disposition | 35,00 | 6,19k | -50,04% |
| 2026-01-20 | Ms. Bethany J. CavanaghSenior VP of Finance, Treasurer & Principal Accounting Officer | -3,03k | 91,38k | Automatic Disposition | 30,12 | 12,39k | -19,68% |
| 2026-01-15 | Dr. Christine P. BellonChief Legal Officer & Corporate Secretary | -18,63k | 644,83k | Automatic Disposition | 33,62 - 35,40 | 43,91k | -29,79% |
| 2025-12-31 | Mr. Sravan Kumar EmanyCFO | -6,29k | 170,57k | Automatic Disposition | 27,10 | 13,71k | -31,47% |
| 2025-12-31 | Dr. Christine P. BellonChief Legal Officer & Corporate Secretary | -1,25k | 33,98k | Automatic Disposition | 27,10 | 62,54k | -1,97% |
| 2025-10-01 | Ms. Bethany J. CavanaghSenior VP of Finance, Treasurer & Principal Accounting Officer | -467,00 | 11,46k | Automatic Disposition | 24,53 | 15,42k | -2,94% |
| 2025-10-01 | Dr. Christine P. BellonChief Legal Officer & Corporate Secretary | -373,00 | 9,15k | Automatic Disposition | 24,53 | 59,80k | -0,62% |
| 2025-10-01 | Mr. John M. EvansCEO & Director | -50,00k | 1,19M | Derivative Exercise and Sale | 0,67 - 24,63 | 911,86k | - |
| 2025-07-01 | Dr. Amy SimonChief Medical Officer | -1,25k | 23,96k | Vente | 16,94 - 20,12 | 1,74k | -41,82% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
